Skip to main content
Erschienen in:

26.11.2021 | Brief Report

Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients

verfasst von: Dionicio A. Galarza-Delgado, Jose R. Azpiri-Lopez, Iris J. Colunga-Pedraza, Natalia Guajardo-Jauregui, Alejandra B. Rodriguez-Romero, Salvador Lugo-Perez, Jesus A. Cardenas-de la Garza, Rosa I. Arvizu-Rivera, Diana E. Flores-Alvarado, Octavio Ilizaliturri-Guerra, Gisela Garcia-Arellano, Andrea C. Garza-Acosta

Erschienen in: Clinical Rheumatology | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

The objective was to compare the prevalence of subclinical atherosclerosis and cardiovascular risk (CVR) reclassification using six CVR algorithms and a carotid ultrasound in psoriatic arthritis (PsA) patients and controls. The method was cross-sectional study. A total of 81 patients aged 40–75 years, who fulfilled the 2006 CASPAR criteria and 81 controls matched by age, gender, and comorbidities were recruited. CVR was evaluated according to six CVR algorithms, including Framingham Risk Score (FRS)-lipids, FRS-body mass index (BMI), Atherosclerotic Cardiovascular Disease (ASCVD) Algorithm, Systematic Coronary Risk Evaluation (SCORE), QRISK3, and Reynolds Risk Score (RRS). A carotid ultrasound was performed to identify the presence of carotid plaque (CP) defined as a carotid intima media thickness ≥ 1.2 mm or a focal narrowing of the surrounding lumen ≥ 0.5mm. Patients with presence of CP, classified in the low-moderate risk by the CVR algorithms, were reclassified to a higher risk category. CP was more prevalent in PsA patients (44.4% vs 24.7%, p = 0.008), as was subclinical atherosclerosis (51.9% vs 33.3%, p = 0.017). When comparing the CVR reclassification to a higher risk category, a difference was found in the six CVR algorithms. The reclassification was more prevalent in PsA patients: 30.8% vs 12.3%, p = 0.004 with FRS-lipids; 28.4% vs 9.9%, p = 0.003 with FRS-BMI; 40.7% vs 19.8%, p = 0.003 with SCORE; 30.9% vs 16.0%, p = 0.026 with ASCVD algorithm; 37.0% vs 19.8%, p = 0.015 with RRS; and 33.3% vs 16.0%, p = 0.011 with QRISK3. The CVR algorithms underestimate the actual CVR of PsA patients. A carotid ultrasound should be considered as part of the CVR evaluation of PsA patients.

Key points

Subclinical atherosclerosis was more prevalent in psoriatic arthritis patients than controls.
Cardiovascular risk reclassification, through a carotid ultrasound, according to traditional cardiovascular risk algorithms was more common in psoriatic arthritis patients.
The cardiovascular risk algorithm that showed the lowest reclassification rate in psoriatic arthritis patients was the FRS-BMI.
All cardiovascular risk algorithms underestimate the actual risk of psoriatic arthritis patients, preventing the initiation of an adequate cardiovascular treatment.
Literatur
4.
Zurück zum Zitat Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Sodergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28. https://doi.org/10.1136/annrheumdis-2016-209775CrossRefPubMed Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Sodergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28. https://​doi.​org/​10.​1136/​annrheumdis-2016-209775CrossRefPubMed
5.
Zurück zum Zitat Martinez-Vidal MP, Andres M, Jovani V, Santos-Ramirez C, Romera C, Fernandez-Carballido C (2020) Role of carotid ultrasound and systematic coronary risk evaluation charts for the cardiovascular risk stratification of patients with psoriatic arthritis. J Rheumatol 47(5):682–689. https://doi.org/10.3899/jrheum.181223CrossRefPubMed Martinez-Vidal MP, Andres M, Jovani V, Santos-Ramirez C, Romera C, Fernandez-Carballido C (2020) Role of carotid ultrasound and systematic coronary risk evaluation charts for the cardiovascular risk stratification of patients with psoriatic arthritis. J Rheumatol 47(5):682–689. https://​doi.​org/​10.​3899/​jrheum.​181223CrossRefPubMed
9.
Zurück zum Zitat Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Garcia-Colunga JI, Arvizu-Rivera RI, Martinez-Moreno A, Villarreal-Perez JZ, Elizondo-Riojas G, Garza Elizondo MA (2016) Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Clin Rheumatol 35(11):2823–2827. https://doi.org/10.1007/s10067-016-3312-zCrossRefPubMed Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Garcia-Colunga JI, Arvizu-Rivera RI, Martinez-Moreno A, Villarreal-Perez JZ, Elizondo-Riojas G, Garza Elizondo MA (2016) Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Clin Rheumatol 35(11):2823–2827. https://​doi.​org/​10.​1007/​s10067-016-3312-zCrossRefPubMed
15.
Zurück zum Zitat Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2):S49-73. https://doi.org/10.1161/01.cir.0000437741.48606.98CrossRefPubMed Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2):S49-73. https://​doi.​org/​10.​1161/​01.​cir.​0000437741.​48606.​98CrossRefPubMed
16.
Zurück zum Zitat Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, group Sp (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003. https://doi.org/10.1016/s0195-668x(03)00114-3CrossRefPubMed Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, group Sp (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003. https://​doi.​org/​10.​1016/​s0195-668x(03)00114-3CrossRefPubMed
19.
Zurück zum Zitat Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS, American Society of Echocardiography Carotid Intima-Media Thickness Task F (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21(2):93–111. https://doi.org/10.1016/j.echo.2007.11.011 (quiz 189-190)CrossRefPubMed Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS, American Society of Echocardiography Carotid Intima-Media Thickness Task F (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21(2):93–111. https://​doi.​org/​10.​1016/​j.​echo.​2007.​11.​011 (quiz 189-190)CrossRefPubMed
21.
Zurück zum Zitat Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Arvizu-Rivera RI, Martinez-Moreno A, Ramos-Cazares RE, Abundis-Marquez EE, Guillen-Lozoya AH, Davila-Jimenez JA, Guillen-Gutierrez CY, Elizondo-Riojas G (2018) The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients. Clin Rheumatol 37(9):2373–2380. https://doi.org/10.1007/s10067-018-4181-4CrossRefPubMed Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Arvizu-Rivera RI, Martinez-Moreno A, Ramos-Cazares RE, Abundis-Marquez EE, Guillen-Lozoya AH, Davila-Jimenez JA, Guillen-Gutierrez CY, Elizondo-Riojas G (2018) The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients. Clin Rheumatol 37(9):2373–2380. https://​doi.​org/​10.​1007/​s10067-018-4181-4CrossRefPubMed
22.
Zurück zum Zitat Palmou-Fontana N, Martinez-Lopez D, Corrales A, Rueda-Gotor J, Genre F, Armesto S, Gonzalez-Lopez MA, Quevedo-Abeledo JC, Portilla-Gonzalez V, Blanco R, Hernandez JL, Llorca J, Gonzalez-Gay MA, Ferraz-Amaro I (2020) Disease activity influences cardiovascular risk reclassification based on carotid ultrasound in patients with psoriatic arthritis. J Rheumatol 47(9):1344–1353. https://doi.org/10.3899/jrheum.190729CrossRefPubMed Palmou-Fontana N, Martinez-Lopez D, Corrales A, Rueda-Gotor J, Genre F, Armesto S, Gonzalez-Lopez MA, Quevedo-Abeledo JC, Portilla-Gonzalez V, Blanco R, Hernandez JL, Llorca J, Gonzalez-Gay MA, Ferraz-Amaro I (2020) Disease activity influences cardiovascular risk reclassification based on carotid ultrasound in patients with psoriatic arthritis. J Rheumatol 47(9):1344–1353. https://​doi.​org/​10.​3899/​jrheum.​190729CrossRefPubMed
23.
Zurück zum Zitat Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Wah-Suarez M, Arvizu-Rivera RI, Martinez-Moreno A, Ramos-Cazares RE, Torres-Quintanilla FJ, Valdovinos-Banuelos A, Esquivel-Valerio JA, Garza-Elizondo MA (2017) Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis. Rheumatol Int 37(9):1507–1511. https://doi.org/10.1007/s00296-017-3769-3CrossRefPubMed Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Wah-Suarez M, Arvizu-Rivera RI, Martinez-Moreno A, Ramos-Cazares RE, Torres-Quintanilla FJ, Valdovinos-Banuelos A, Esquivel-Valerio JA, Garza-Elizondo MA (2017) Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis. Rheumatol Int 37(9):1507–1511. https://​doi.​org/​10.​1007/​s00296-017-3769-3CrossRefPubMed
24.
Zurück zum Zitat Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, Investigators A (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295(13):1556–1565. https://doi.org/10.1001/jama.295.13.jpc60002CrossRefPubMed Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, Investigators A (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295(13):1556–1565. https://​doi.​org/​10.​1001/​jama.​295.​13.​jpc60002CrossRefPubMed
Metadaten
Titel
Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients
verfasst von
Dionicio A. Galarza-Delgado
Jose R. Azpiri-Lopez
Iris J. Colunga-Pedraza
Natalia Guajardo-Jauregui
Alejandra B. Rodriguez-Romero
Salvador Lugo-Perez
Jesus A. Cardenas-de la Garza
Rosa I. Arvizu-Rivera
Diana E. Flores-Alvarado
Octavio Ilizaliturri-Guerra
Gisela Garcia-Arellano
Andrea C. Garza-Acosta
Publikationsdatum
26.11.2021
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 5/2022
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-06002-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.